Vol 7, Issue 1, 2014 ISSN - 0974-2441 Research Article EVALUATING THE EFFECT OF MEDICAL REPRESENTATIVE ON PHYSICIAN PRESCRIBING PATTERN IN IRAQ EHAB MUDHER MIKHAEL 1 University of Baghdad - College of pharmacy –Clinical pharmacy department. Email: ehab_pharma84@yahoo.com Received: 6 November 2013, Revised and Accepted: 5 December 2013 ABSTRACT Objective: Evaluation of the interaction between medical representatives (MRs) and physicians and the effect of such interaction on physician
Words: 1909 - Pages: 8
Industry Trends According to Standard and Poor’s industry service, in the past few years, the pharmaceutical industry has been subjected to heightened competition from generic drugmakers, unprecedented pricing pressure from payers, and hard-to-control inflation in research and development budgets. Furthermore, the industry has been experiencing a decline in R&D productivity, with a lack of innovative new products being launched in recent years. The industry has suffered due to these problems
Words: 2026 - Pages: 9
strategy to enter the Indian market? It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of
Words: 496 - Pages: 2
Week 4 Learning Team Reflection Faruque Ahamed, Siead Hasan, Ralph Kitson, and Sangeeta Walia-Chopra FIN/571 February 10, 2014 Beatrice Jones In Groton, Connecticut stands one of the largest industrial drug complexes on earth. The structure is 2.8 million square feet and it rests on a place of land that is approximately 160 acres of land. The site was designed to offer the best to drug researchers including flexible office space with mobile accommodations. Such a space offers 250,000
Words: 1164 - Pages: 5
CORPORATE SOCIAL RESPONSIBILITY IN THE PHARMACEUTICAL INDUSTRY: BETWEEN TREND AND NECESSITY by Cecile Oger BSc. (Honours) Chemistry with Business Administration Kingston University London, UK, 1995 A thesis presented to Ryerson University In partial fulfillment of the requirements for the degree of Master of Business Administration In the program of Master of Business Administration Toronto, Ontario, Canada, 2009 © Cecile Oger 2009 Library and Archives Canada Bibliothèque
Words: 28145 - Pages: 113
Global Pharmaceutical Market - Overview The increasing generics share and shift of the industry towards emerging markets is causing margin pressure on global pharma players and forcing them to invest in these new markets Global Pharmaceutical Market The pharmaceutical market was $ 820Bn in Other Patented 86% 83% 81% 79% 2009, growing at a CAGR of 9% over 200309 Generics is growing at double the rate of the Generics 2004 2006 2008 2010E total industry (18% CAGR), while
Words: 3256 - Pages: 14
1- Derive three opportunities and three threats for GSK by first making the PESTEL analysis of the macro-environment surrounding the pharmaceutical industry. (9 points) * PESTEL analysis of the pharmaceutical industry: Political: Since the creation of healthcare insurance, companies have to conform themselves to two kinds of systems: 1) The universal system applied for example in France, with less demand in new technologies. 2) The very selective anglo-saxon system which is looking for high
Words: 1150 - Pages: 5
PHARMACEUTICAL INDUSTRY : SWALLOWING A BETTER PILL 1. INTRODUCTION The global pharmaceutical industry is a multinational industry that develops, manufactures, and sells drugs licensed for the treatment. Pharmaceutical companies can sell generic or patent medicines. Health products of the pharmaceutical industry is very often found on the market in the world so that makes the brand of the pharmaceutical industry they are known in the world because of the many products sold are certainly many
Words: 1624 - Pages: 7
(Med J Indones 2011; 20:149-53) Abstract Bioequivalence (BE) study is required to show whether a generic copy product can be interchangeable with the brand innovator product. The aim of this article is to provide the rationale for conducting BE studies, the main products requiring BE studies, the design and conduct of BE studies in general, with focus on clopidogrel. All of the clopidogrel generic products in Indonesia have been shown to be BE to the innovator product Plavix® and they contain API
Words: 3646 - Pages: 15
cases, but if you need drugs for diabetes no real substitute for this outside of medication) • High product differentiation (drugs are developed for specific purposes and have patent protection, differentiation decreases after patent expiry when generics can enter) • Moderate brand loyalty LOW Power of buyers based on above. 3) Threat from substitute products What are substitute products for prescription drugs? There are few here, things like natural medicines,
Words: 611 - Pages: 3
